Literature DB >> 17254520

Metabolic syndrome and cardiometabolic risk in PCOS.

Andrea J Cussons1, Bronwyn G A Stuckey, Gerald F Watts.   

Abstract

The cardiovascular risk associated with the polycystic ovary syndrome (PCOS) has recently attracted much interest. Women with PCOS are more likely to fulfill the diagnosis of the metabolic syndrome, a cluster of related cardiometabolic factors known to predict long-term risk of cardiovascular disease and type 2 diabetes. We review the literature pertaining to the link between the metabolic syndrome, cardiovascular disease, and PCOS. We focus on the influence of obesity and hyperandrogenemia, and on strategies for identifying cardiovascular risk in PCOS.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17254520     DOI： 10.1007/s11892-007-0012-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   5.430


  51 in total

1.  How prevalent is metabolic syndrome in women with polycystic ovary syndrome?

Authors:  Ricardo Azziz
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-03

2.  Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.

Authors:  David A Ehrmann; David R Liljenquist; Kristen Kasza; Ricardo Azziz; Richard S Legro; Mahmoud N Ghazzi
Journal:  J Clin Endocrinol Metab       Date:  2005-10-25       Impact factor: 5.958

3.  Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome.

Authors:  E O Talbott; J V Zborowski; J R Rager; M Y Boudreaux; D A Edmundowicz; D S Guzick
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

4.  Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.

Authors:  E Diamanti-Kandarakis; G Spina; C Kouli; I Migdalis
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

5.  Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.

Authors:  Giancarlo Paradisi; Helmut O Steinberg; Marguerite K Shepard; Ginger Hook; Alain D Baron
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

6.  Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women.

Authors:  E Dahlgren; P O Janson; S Johansson; L Lapidus; A Odén
Journal:  Acta Obstet Gynecol Scand       Date:  1992-12       Impact factor: 3.636

7.  Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome.

Authors:  Francesco Orio; Stefano Palomba; Teresa Cascella; Biagio De Simone; Sebastiano Di Biase; Tiziana Russo; Donato Labella; Fulvio Zullo; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

8.  Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.

Authors:  E Faloia; P Canibus; C Gatti; F Frezza; M Santangelo; G G M Garrapa; M Boscaro
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 9.  Polycystic ovary syndrome and cardiovascular disease: a premature association?

Authors:  Richard S Legro
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

10.  Hemostatic and metabolic variables in women with polycystic ovary syndrome.

Authors:  E Dahlgren; P O Janson; S Johansson; L Lapidus; G Lindstedt; L Tengborn
Journal:  Fertil Steril       Date:  1994-03       Impact factor: 7.329
View more
  9 in total

1.  Defining the role of bariatric surgery in polycystic ovarian syndrome patients.

Authors:  Shaveta M Malik; Michael L Traub
Journal:  World J Diabetes       Date:  2012-04-15

Review 2.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

Review 3.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

4.  Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.

Authors:  Zelija Velija-Asimi; Azra Burekovic; Tanja Dujic; Amela Dizdarevic-Bostandzic; Sabina Semiz
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

5.  Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.

Authors:  Surleen Kaur; Kellie J Archer; M Gouri Devi; Alka Kriplani; Jerome F Strauss; Rita Singh
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

6.  Identification of Variants in Mitochondrial D-Loop and OriL Region and Analysis of Mitochondrial DNA Copy Number in Women with Polycystic Ovary Syndrome.

Authors:  Pallavi Shukla; Srabani Mukherjee; Anushree Patil
Journal:  DNA Cell Biol       Date:  2020-06-08       Impact factor: 3.311

7.  Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome.

Authors:  Chunzhu Li; Chuan Xing; Jiaqi Zhang; Han Zhao; Wenjing Shi; Bing He
Journal:  J Transl Med       Date:  2021-04-13       Impact factor: 5.531

Review 8.  Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients.

Authors:  Tabatha Petrillo; Elisa Semprini; Veronica Tomatis; Melania Arnesano; Fedora Ambrosetti; Christian Battipaglia; Alessandra Sponzilli; Francesco Ricciardiello; Andrea R Genazzani; Alessandro D Genazzani
Journal:  Biomedicines       Date:  2022-08-09

Review 9.  The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.

Authors:  Joselyn Rojas; Mervin Chávez-Castillo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.